3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material(Hydrogel, Living Cells), Application (Research, Clinical), End user (Biopharma, Academia) - Global Forecast to 2027

3Dバイオプリンティングのグローバル市場予測(~2027):3Dバイオプリンター、バイオインク

◆タイトル:3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material(Hydrogel, Living Cells), Application (Research, Clinical), End user (Biopharma, Academia) - Global Forecast to 2027
◆商品コード:BT4971-22
◆調査・発行会社:MarketsandMarkets
◆発行日:2022年7月12日
◆ページ数:259
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥0見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社の最新調査レポートによると、世界の3Dバイオプリンティング市場規模は、2022年13億ドルから2027年33億ドルまで年平均20.8%拡大すると見込まれています。当書では3Dバイオプリンティングの世界市場を総合的に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、コンポーネント別(3Dバイオプリンター、バイオインク)分析、材料別(ヒドロゲル、細胞外マトリックス、その他)分析、用途別(研究、臨床)分析、エンドユーザー別(研究・学術機関、バイオ医薬品会社、病院)分析、地域別分析、競争状況、企業情報など、以下の項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の3Dバイオプリンティング市場規模:コンポーネント別(3Dバイオプリンター、バイオインク)
・世界の3Dバイオプリンティング市場規模:材料別(ヒドロゲル、細胞外マトリックス、その他)
・世界の3Dバイオプリンティング市場規模:用途別(研究、臨床)
・世界の3Dバイオプリンティング市場規模:エンドユーザー別(研究・学術機関、バイオ医薬品会社、病院)
・世界の3Dバイオプリンティング市場規模:地域別
・競争状況
・企業情報

“The global 3D Bioprinting market is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 3.3 billion by 2027, at a CAGR of 20.8% during the forecast period.”
Factors such as technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities drive the market growth. However,factors likedearth of skilled professionals and high development and production costs are restraining the growth of this market.

“The 3D Bioprinterssegmentaccounted for the highest growth rate in the 3D Bioprintingmarket, bycomponent, during the forecast period”
In 2021, the 3D Bioprinters segment accounted for the highest growth rate. In biological sciences and the bioengineering field, 3D bioprinters help in printing living cells layer-by-layer. The idea of printing entire organs—such as the liver, teeth, heart, ears, and lungs—grown from samples of an individual’s body tissue is in process and gaining tremendous attention worldwide and thus, favoring growth of this market.

“Asia Pacific: The fastest-growing regionin the3D Bioprintingmarket”
The Asia Pacific market is estimated to record the highest CAGR during the forecast period. The high growth rate of this market can beattributed to theincreasing research activities, growing demand for organ transplants, increasing number of initiatives by market players for expanding their presence in the APAC, and the higher adoption of stem cell research in several Asian countries.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 80%and Demand Side 20%
• By Designation: C-level (Managers) – 45%, D-level(CXOs, Directors)- 30%, and Others (Executives) – 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%

List of Companies Profiled in the Report:
• BICO Group AB (US)
• Organovo Holdings Inc. (US)
• Allevi, Inc. (part of 3D Systems, Inc.) (US)
• CollPlant Biotechnologies Ltd. (Israel)
• regenHU (Switzerland)
• EnvisionTEC GmbH (part of Desktop Metal) (Germany)
• Aspect Biosystems Ltd. (Canada)
• Advanced Solutions Life Sciences, LLC (US)
• Cyfuse Biomedical K.K. (Japan)
• ROKIT Healthcare, Inc. (South Korea)
• Regenovo Biotechnology Co., Ltd. (part of Shining 3D Tech Co., Ltd.) (China)
• Pandorum Technologies Pvt. Ltd. (India)
• Foldink Life Science Technologies (Armenia)
• Revotek Co., Ltd. (US)
• Precise Bio (US)
• Brinter (Finland)
• Prellis Biologics (US)
• Regemat 3D (Spain)
• 3DBio Therapeutics (US)
• Tissue Regeneration Systems Inc. (US)
• Poietis (France)
• SunP Biotech, LLC (US)
• Vivax Bio, LLC (US)
• GeSiM mbH (Germany)
• Manchester BIOGEL (UK)

Research Coverage:
This report provides a detailed picture of theglobal 3D Bioprinting Market. It aims at estimating the size and future growth potential of the market across different segments such as thecomponent, material, application, end user and region. The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D BioprintingMarketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, challenges, restraints,trends,and opportunities.

【レポートの目次】

1 INTRODUCTION 37
1.1 OBJECTIVES OF THE STUDY 37
1.2 MARKET DEFINITION 37
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY 38
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED 38
1.3.2 YEARS CONSIDERED FOR THE STUDY 39
1.4 CURRENCY 39
1.5 LIMITATIONS 39
1.6 STAKEHOLDERS 40
1.7 SUMMARY OF CHANGES 40
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH DATA 42
FIGURE 1 RESEARCH DESIGN 42
2.1.1 SECONDARY DATA 43
2.1.1.1 Key data from secondary sources 43
2.1.2 PRIMARY DATA 44
FIGURE 2 BREAKDOWN OF PRIMARIES: 3D BIOPRINTING MARKET 44
2.2 MARKET ESTIMATION METHODOLOGY 45
FIGURE 3 3D BIOPRINTING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021 45
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021 46
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 47
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 47
2.3 MARKET GROWTH RATE PROJECTIONS 48
FIGURE 6 3D BIOPRINTING MARKET (SUPPLY SIDE): CAGR PROJECTIONS 48
FIGURE 7 3D BIOPRINTING MARKET (DEMAND SIDE): GROWTH ANALYSIS OF
DEMAND-SIDE FACTORS 49
2.4 DATA TRIANGULATION 49
FIGURE 8 DATA TRIANGULATION METHODOLOGY 50
2.5 RESEARCH ASSUMPTIONS 50
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS 51
2.6 RISK ANALYSIS 51
3 EXECUTIVE SUMMARY 52
FIGURE 9 3D BIOPRINTING MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION) 52
FIGURE 10 3D BIOPRINTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 53
FIGURE 11 3D BIOPRINTING MARKET, BY MATERIAL, 2022 VS. 2027 (USD MILLION) 54
FIGURE 12 3D BIOPRINTING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 54
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF 3D BIOPRINTING MARKET 55
4 PREMIUM INSIGHTS 56
4.1 3D BIOPRINTING MARKET OVERVIEW 56
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS IN 3D BIOPRINTING INDUSTRY
TO DRIVE MARKET 56
4.2 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT AND COUNTRY (2021) 57
FIGURE 15 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN 3D BIOPRINTING MARKET IN 2021 57
4.3 3D BIOPRINTING MARKET SHARE, BY MATERIAL, 2022 VS. 2027 57
FIGURE 16 LIVING CELLS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027 57
4.4 3D BIOPRINTING MARKET SHARE, BY END USER, 2022 58
FIGURE 17 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES ARE LARGEST
END USERS OF 3D BIOPRINTING MARKET 58
4.5 3D BIOPRINTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 58
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH FROM
2022 TO 2027 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
FIGURE 19 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 59
5.2.1 DRIVERS 60
5.2.1.1 Increasing use of 3D bioprinting in pharmaceutical and cosmetology industries 60
5.2.1.2 Developments in 3D bioprinting for tissue and organ regeneration applications 60
5.2.1.3 Rising public and private funding to support bioprinting research activities 61
5.2.1.4 Technological advancements in 3D bioprinting industry 61
5.2.2 RESTRAINTS 62
5.2.2.1 Dearth of skilled professionals 62
5.2.2.2 High development and production costs 62
5.2.2.3 Lack of regulatory guidelines governing 3D bioprinting 62
5.2.3 OPPORTUNITIES 63
5.2.3.1 Rising demand for organ transplant 63
5.2.3.2 Growing awareness of 3D bioprinting 63
5.2.3.3 Growing demand for regenerative medicine and stem cell research 64
5.2.4 CHALLENGES 64
5.2.4.1 Socioethical concerns related to use of 3D-bioprinted products 64
5.2.4.2 High cost of 3D bioprinting 65
5.2.4.3 Process control and understanding of 3D bioprinters 65

5.3 RANGES/SCENARIOS 66
FIGURE 20 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES
ON GROWTH OF 3D BIOPRINTING MARKET 66
5.4 IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET 67
FIGURE 21 3D BIOPRINTING MARKET SCENARIO PRE- AND POST-COVID-19,
2020–2022 67
FIGURE 22 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68
5.5 PRICING ANALYSIS 68
5.6 TECHNOLOGY ANALYSIS 69
TABLE 1 COMPARISON OF BIOPRINTING TECHNIQUES 69
TABLE 2 ADVANTAGES AND DISADVANTAGES OF 3D BIOPRINTING TECHNIQUES 69
5.7 PATENT ANALYSIS 70
FIGURE 23 PATENT APPLICATIONS FOR 3D BIOPRINTING MARKET,
JANUARY 2011–MAY 2022 70
TABLE 3 INDICATIVE LIST OF PATENTS IN 3D BIOPRINTING MARKET 70
5.8 VALUE CHAIN ANALYSIS 71
FIGURE 24 VALUE CHAIN ANALYSIS OF 3D BIOPRINTING MARKET: RAW MATERIAL
AND MANUFACTURING PHASE CONTRIBUTE MAXIMUM VALUE 72
5.8.1 RESEARCH & DEVELOPMENT (R&D) 72
5.8.2 MANUFACTURING & ASSEMBLY 72
5.8.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 72
5.9 SUPPLY CHAIN ANALYSIS 72
5.9.1 PROMINENT COMPANIES 72
5.9.2 SMALL AND MEDIUM-SIZED ENTERPRISES (SMES) 73
5.9.3 END USERS 73
FIGURE 25 3D BIOPRINTING MARKET: SUPPLY CHAIN ANALYSIS 73
5.10 ECOSYSTEM ANALYSIS OF 3D BIOPRINTING MARKET 74
TABLE 4 SUPPLY CHAIN ECOSYSTEM 74
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023 75
TABLE 5 3D BIOPRINTING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 75
5.12 REGULATORY ANALYSIS 76
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 7 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
5.13 PORTER’S FIVE FORCES ANALYSIS 79
TABLE 10 3D BIOPRINTING MARKET: PORTER’S FIVE FORCES ANALYSIS 79
5.13.1 THREAT OF NEW ENTRANTS 79
5.13.2 THREAT OF SUBSTITUTES 79
5.13.3 BARGAINING POWER OF SUPPLIERS 79
5.13.4 BARGAINING POWER OF BUYERS 79
5.13.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 79
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 80
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 80
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF
3D BIOPRINTING PRODUCTS 80
5.14.2 BUYING CRITERIA FOR 3D BIOPRINTING PRODUCTS 80
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 80
6 3D BIOPRINTING MARKET, BY COMPONENT 81
6.1 INTRODUCTION 82
TABLE 11 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 82
6.2 3D BIOPRINTERS 82
6.2.1 3D BIOPRINTERS MARKET, BY TECHNOLOGY 82
TABLE 12 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 83
TABLE 13 3D BIOPRINTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 83
TABLE 14 NORTH AMERICA: 3D BIOPRINTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 83
TABLE 15 EUROPE: 3D BIOPRINTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 84
TABLE 16 ASIA PACIFIC: 3D BIOPRINTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 84
6.2.1.1 Microextrusion bioprinting 84
6.2.1.1.1 Increasing research in microextrusion fueling adoption
of this technology 84
TABLE 17 MICROEXTRUSION 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION) 85
TABLE 18 NORTH AMERICA: MICROEXTRUSION 3D BIOPRINTING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 86
TABLE 19 EUROPE: MICROEXTRUSION 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 86
TABLE 20 ASIA PACIFIC: MICROEXTRUSION 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.2.1.2 Inkjet 3D bioprinting 87
6.2.1.2.1 High cell viability and low cost resulted in increased demand for inkjet 3D bioprinting 87
TABLE 21 INKJET 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION) 88
TABLE 22 NORTH AMERICA: INKJET 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 88
TABLE 23 EUROPE: INKJET 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 88
TABLE 24 ASIA PACIFIC: INKJET 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 89
6.2.1.3 Laser-assisted bioprinting 89
6.2.1.3.1 Laser-assisted bioprinting among highest-resolution bioprinting technologies available in 3D bioprinting industry 89
TABLE 25 LASER-ASSISTED 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION) 90
TABLE 26 NORTH AMERICA: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 27 EUROPE: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 91
TABLE 28 ASIA PACIFIC: LASER-ASSISTED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 91
6.2.1.4 Stereolithography-based bioprinting 92
6.2.1.4.1 Stereolithography offers high printing quality, speed,
and cell viability 92
TABLE 29 STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION) 92
TABLE 30 NORTH AMERICA: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 31 EUROPE: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 93
TABLE 32 ASIA PACIFIC: STEREOLITHOGRAPHY-BASED 3D BIOPRINTING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 93
6.2.1.5 Magnetic 3D bioprinting 94
6.2.1.5.1 Accuracy and speed are major advantages of magnetic
3D bioprinting 94
TABLE 33 MAGNETIC 3D BIOPRINTING MARKET, BY REGION,
2020–2027 (USD MILLION) 94
TABLE 34 NORTH AMERICA: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 35 EUROPE: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 95
TABLE 36 ASIA PACIFIC: MAGNETIC 3D BIOPRINTING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 96
6.2.1.6 Other technologies 96
TABLE 37 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2020–2027 (USD MILLION) 96
TABLE 38 NORTH AMERICA: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 39 EUROPE: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 40 ASIA PACIFIC: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2020–2027 (USD MILLION) 98
6.3 BIOINKS 98
TABLE 41 BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 42 BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION) 99
TABLE 43 NORTH AMERICA: BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 99
TABLE 44 EUROPE: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 45 ASIA PACIFIC: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
6.3.1 NATURAL BIOINKS 100
6.3.1.1 Natural bioinks most preferred bioink in 3D bioprinting process 100
TABLE 46 NATURAL BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION) 101
TABLE 47 NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 101
TABLE 48 EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 101
TABLE 49 ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 102
6.3.2 HYBRID BIOINKS 102
6.3.2.1 Hybrid bioinks possess high mechanical strength and biocompatibility 102
TABLE 50 HYBRID BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION) 102
TABLE 51 NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 103
TABLE 52 EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 103
TABLE 53 ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 103
6.3.3 SYNTHETIC BIOINKS 104
6.3.3.1 Improved mechanical strength and consistency offered
by synthetic bioinks to drive market 104
TABLE 54 SYNTHETIC BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 55 NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 104
TABLE 56 EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 105
TABLE 57 ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 105
7 3D BIOPRINTING MARKET, BY MATERIAL 106
7.1 INTRODUCTION 107
TABLE 58 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 107
7.2 LIVING CELLS 107
7.2.1 ETHICAL ISSUES ASSOCIATED WITH USE OF LIVING CELLS IN ORGAN DEVELOPMENT TO HAMPER MARKET GROWTH 107
TABLE 59 3D BIOPRINTING MARKET FOR LIVING CELLS, BY REGION,
2020–2027 (USD MILLION) 108
TABLE 60 NORTH AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS,
BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 61 EUROPE: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY,
2020–2027 (USD MILLION) 109
TABLE 62 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 109

7.3 HYDROGELS 110
7.3.1 DYNAMIC PROPERTIES OF HYDROGELS SUPPORT THEIR ADOPTION
IN 3D TISSUE ENGINEERING 110
TABLE 63 3D BIOPRINTING MARKET FOR HYDROGELS, BY REGION,
2020–2027 (USD MILLION) 110
TABLE 64 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 65 EUROPE: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY,
2020–2027 (USD MILLION) 111
TABLE 66 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION) 112
7.4 EXTRACELLULAR MATRICES 112
7.4.1 ECM HAS EMERGED AS PROMISING TOOL IN TISSUE ENGINEERING 112
TABLE 67 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2020–2027 (USD MILLION) 113
TABLE 68 NORTH AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 69 EUROPE: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES,
BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 70 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES,
BY COUNTRY, 2020–2027 (USD MILLION) 114
7.5 OTHER BIOMATERIALS 115
TABLE 71 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS, BY REGION,
2020–2027 (USD MILLION) 115
TABLE 72 NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS,
BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 73 EUROPE: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS,
BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 74 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER BIOMATERIALS,
BY COUNTRY, 2020–2027 (USD MILLION) 117
8 3D BIOPRINTING MARKET, BY APPLICATION 118
8.1 INTRODUCTION 119
TABLE 75 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119
8.2 RESEARCH APPLICATIONS 119
TABLE 76 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2020–2027 (USD MILLION) 119
TABLE 77 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 120
TABLE 78 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 79 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 80 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 121
8.2.1 DRUG RESEARCH 122
8.2.1.1 Drug research is largest and fastest-growing segment of
3D bioprinting market 122
TABLE 81 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY REGION, 2020–2027 (USD MILLION) 122
TABLE 82 NORTH AMERICA: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 83 EUROPE: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 84 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 124
8.2.2 REGENERATIVE MEDICINE 124
8.2.2.1 Growing demand for organ transplant to support market growth 124
TABLE 85 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2020–2027 (USD MILLION) 125
TABLE 86 NORTH AMERICA: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 87 EUROPE: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION) 126
TABLE 88 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION) 126
8.2.3 3D CELL CULTURE 127
8.2.3.1 Rising focus on developing alternatives to animal testing to drive market for 3D cell culture 127
TABLE 89 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY REGION, 2020–2027 (USD MILLION) 127
TABLE 90 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 91 EUROPE: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 92 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION) 129
8.3 CLINICAL APPLICATIONS 129
TABLE 93 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 94 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 130
TABLE 95 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 130
TABLE 96 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 97 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 131
8.3.1 SKIN 132
8.3.1.1 Growing number of aesthetic and reconstruction surgeries to propel market growth 132
TABLE 98 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 132
TABLE 99 NORTH AMERICA: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 100 EUROPE: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 101 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 134
8.3.2 BONE AND CARTILAGE 134
8.3.2.1 Increasing incidence of musculoskeletal conditions to drive demand for bone grafts 134
TABLE 102 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 135
TABLE 103 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 135
TABLE 104 EUROPE: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 105 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 136
8.3.3 BLOOD VESSELS 137
8.3.3.1 Increasing research activities focused on 3D bioprinting of blood vessels major factor driving market 137
TABLE 106 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 137
TABLE 107 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 137
TABLE 108 EUROPE: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 138
TABLE 109 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 138
8.3.4 OTHER CLINICAL APPLICATIONS 139
TABLE 110 LIST OF ONGOING CLINICAL TRIALS 139
TABLE 111 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 140
TABLE 112 NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 140
TABLE 113 EUROPE: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 114 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 141
9 3D BIOPRINTING MARKET, BY END USER 142
9.1 INTRODUCTION 143
TABLE 115 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 143
9.2 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES 143
9.2.1 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES ARE FASTEST-GROWING END USERS OF 3D BIOPRINTING MARKET 143
TABLE 116 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 144
TABLE 117 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 144
TABLE 118 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 145
TABLE 119 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 145
9.3 BIOPHARMACEUTICAL COMPANIES 146
9.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE ADOPTION OF 3D BIOPRINTING 146
TABLE 120 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2027 (USD MILLION) 146
TABLE 121 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 147
TABLE 122 EUROPE: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 147
TABLE 123 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 148
9.4 HOSPITALS 148
9.4.1 3D PRINTING OFFERS A CUSTOMIZED SURGICAL PLANNING TOOL FOR HOSPITALS 148
TABLE 124 3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 149
TABLE 125 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 149
TABLE 126 EUROPE: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 127 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 150
10 3D BIOPRINTING MARKET, BY REGION 151
10.1 INTRODUCTION 152
TABLE 128 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION) 152
10.2 NORTH AMERICA 152
FIGURE 28 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT 153
TABLE 129 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 130 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 154
TABLE 131 NORTH AMERICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 154
TABLE 132 NORTH AMERICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 133 NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 155
TABLE 134 NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
TABLE 135 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 137 NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 156

10.2.1 US 156
10.2.1.1 US dominates global 3D bioprinting market 156
TABLE 138 US: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 157
TABLE 139 US: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 157
TABLE 140 US: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 141 US: 3D BIOINKS MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 158
TABLE 142 US: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 145 US: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 159
10.2.2 CANADA 160
10.2.2.1 Government initiatives to support growth of 3D bioprinting market in Canada 160
TABLE 146 CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 160
TABLE 147 CANADA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 161
TABLE 148 CANADA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 161
TABLE 150 CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 153 CANADA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 163
10.3 EUROPE 163
TABLE 154 EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 163
TABLE 155 EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 164
TABLE 156 EUROPE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 164
TABLE 157 EUROPE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 158 EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 165
TABLE 159 EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 160 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 161 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 162 EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 166
10.3.1 GERMANY 166
10.3.1.1 Increasing demand for organ transplant to drive market 166
TABLE 163 GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 167
TABLE 164 GERMANY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 167
TABLE 165 GERMANY: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 166 GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 168
TABLE 167 GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 168 GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 169 GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 170 GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 169
10.3.2 UK 170
10.3.2.1 Increased funding and grants to support research activities related to 3D bioprinting in UK 170
TABLE 171 UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 170
TABLE 172 UK: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 171
TABLE 173 UK: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 174 UK: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 171
TABLE 175 UK: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 176 UK: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 177 UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 178 UK: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 173
10.3.3 FRANCE 173
10.3.3.1 Rising adoption of 3D bioprinting technology to propel market growth 173
TABLE 179 FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 174
TABLE 180 FRANCE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 174
TABLE 181 FRANCE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 182 FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 175
TABLE 183 FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 184 FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 185 FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 186 FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 176
10.3.4 ITALY 176
10.3.4.1 Italy is leading life science research hub in Europe 176
TABLE 187 ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 177
TABLE 188 ITALY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 178
TABLE 189 ITALY: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 190 ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 178
TABLE 191 ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 179
TABLE 192 ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 193 ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 194 ITALY: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 180
10.3.5 SPAIN 180
10.3.5.1 Increasing funding from private and public organizations to aid market growth in Spain 180
TABLE 195 SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 181
TABLE 196 SPAIN: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 181
TABLE 197 SPAIN: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 198 SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 182
TABLE 199 SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 182
TABLE 200 SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 201 SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 202 SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 183
10.3.6 REST OF EUROPE 183
TABLE 203 ROE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 184
TABLE 204 ROE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 184
TABLE 205 ROE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 206 ROE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 185
TABLE 207 ROE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 185
TABLE 208 ROE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 209 ROE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 210 ROE: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 186

10.4 ASIA PACIFIC 187
FIGURE 29 ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT 188
TABLE 211 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 189
TABLE 212 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 189
TABLE 213 ASIA PACIFIC: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 189
TABLE 214 ASIA PACIFIC: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
TABLE 215 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 190
TABLE 216 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 190
TABLE 217 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 218 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 219 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 191
10.4.1 CHINA 192
10.4.1.1 Market in China projected to register significant growth owing to rising regenerative medicine research 192
TABLE 220 CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 192
TABLE 221 CHINA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 193
TABLE 222 CHINA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 223 CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 193
TABLE 224 CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 194
TABLE 225 CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 226 CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 227 CHINA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 195
10.4.2 JAPAN 195
10.4.2.1 Strong research base and government support to drive market for 3D bioprinting in Japan 195
TABLE 228 JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 195
TABLE 229 JAPAN: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 196
TABLE 230 JAPAN: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 231 JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 196
TABLE 232 JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 197
TABLE 233 JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 234 JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 235 JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 198
10.4.3 INDIA 198
10.4.3.1 Initiatives to raise awareness and develop novel products to support market growth 198
TABLE 236 INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 199
TABLE 237 INDIA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 199
TABLE 238 INDIA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 239 INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 200
TABLE 240 INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 200
TABLE 241 INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 242 INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 243 INDIA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 201
10.4.4 SOUTH KOREA 201
10.4.4.1 Increased awareness about 3D bioprinting to drive market in South Korea 201
TABLE 244 SOUTH KOREA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 202
TABLE 245 SOUTH KOREA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 202
TABLE 246 SOUTH KOREA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 247 SOUTH KOREA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 203
TABLE 248 SOUTH KOREA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 203
TABLE 249 SOUTH KOREA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 250 SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 251 SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 204
10.4.5 REST OF ASIA PACIFIC 204
TABLE 252 ROAPAC: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 205
TABLE 253 ROAPAC: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 205
TABLE 254 ROAPAC: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 255 ROAPAC: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 206
TABLE 256 ROAPAC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 257 ROAPAC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 258 ROAPAC: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 207
TABLE 259 ROAPAC: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 207
10.5 LATIN AMERICA 208
10.5.1 GROWING MEDICAL TOURISM TO DRIVE MARKET FOR 3D BIOPRINTING IN LATIN AMERICA 208
TABLE 260 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 208
TABLE 261 LATIN AMERICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 209
TABLE 262 LATIN AMERICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 263 LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 209
TABLE 264 LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 210
TABLE 265 LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 266 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 267 LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 211
10.6 MIDDLE EAST AND AFRICA 211
10.6.1 GROWING RESEARCH EFFORTS TO BOOST MARKET GROWTH 211
TABLE 268 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 212
TABLE 269 MIDDLE EAST AND AFRICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 212
TABLE 270 MIDDLE EAST AND AFRICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 271 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2027 (USD MILLION) 213
TABLE 272 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 213
TABLE 273 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 274 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 275 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION) 214

11 COMPETITIVE LANDSCAPE 215
11.1 OVERVIEW 215
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 215
FIGURE 30 KEY DEVELOPMENTS IN 3D BIOPRINTING MARKET, 2019–2022 215
11.3 MARKET SHARE ANALYSIS 216
FIGURE 31 3D BIOPRINTING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 216
TABLE 276 3D BIOPRINTING MARKET: DEGREE OF COMPETITION 216
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 217
FIGURE 32 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN 3D BIOPRINTING MARKET, 2019–2021 217
11.5 COMPANY EVALUATION QUADRANT 218
11.5.1 STARS 218
11.5.2 EMERGING LEADERS 218
11.5.3 PERVASIVE PLAYERS 218
11.5.4 PARTICIPANTS 218
FIGURE 33 3D BIOPRINTING MARKET: COMPANY EVALUATION QUADRANT, 2021 219
11.6 COMPANY EVALUATION QUADRANT: STARTUPS/SMES 220
11.6.1 PROGRESSIVE COMPANIES 220
11.6.2 STARTING BLOCKS 220
11.6.3 RESPONSIVE COMPANIES 220
11.6.4 DYNAMIC COMPANIES 220
FIGURE 34 3D BIOPRINTING MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2021 221
11.7 COMPANY FOOTPRINT ANALYSIS 222
11.7.1 PRODUCT FOOTPRINT OF COMPANIES 222
TABLE 277 PRODUCT FOOTPRINT OF COMPANIES IN 3D BIOPRINTING MARKET (2021) 222
11.7.2 REGIONAL FOOTPRINT OF COMPANIES 223
TABLE 278 REGIONAL FOOTPRINT OF COMPANIES IN 3D BIOPRINTING MARKET (2021) 223
11.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS 224
TABLE 279 3D BIOPRINTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 224
11.9 COMPETITIVE SCENARIO 224
TABLE 280 KEY PRODUCT LAUNCHES 224
TABLE 281 KEY DEALS 225
TABLE 282 OTHER KEY DEVELOPMENTS 225

12 COMPANY PROFILES 226
12.1 KEY PLAYERS 226
(Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices, Weaknesses and competitive threats)*
12.1.1 BICO GROUP AB 226
TABLE 283 BICO GROUP AB: BUSINESS OVERVIEW 226
FIGURE 35 BICO GROUP AB: COMPANY SNAPSHOT (2021) 227
12.1.2 ORGANOVO HOLDINGS INC. 232
TABLE 284 ORGANOVO HOLDINGS INC.: BUSINESS OVERVIEW 232
FIGURE 36 ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT (2020) 232
12.1.3 ALLEVI, INC. (PART OF 3D SYSTEMS, INC.) 234
TABLE 285 3D SYSTEMS, INC.: BUSINESS OVERVIEW 234
FIGURE 37 3D SYSTEMS, INC.: COMPANY SNAPSHOT (2021) 235
12.1.4 COLLPLANT BIOTECHNOLOGIES LTD. 238
TABLE 286 COLLPLANT BIOTECHNOLOGIES LTD.: BUSINESS OVERVIEW 238
FIGURE 38 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2021) 238
12.1.5 REGENHU 241
TABLE 287 REGENHU: BUSINESS OVERVIEW 241
12.1.6 ENVISIONTEC GMBH (PART OF DESKTOP METAL, INC.) 242
TABLE 288 ENVISIONTEC GMBH: BUSINESS OVERVIEW 242
12.1.7 ASPECT BIOSYSTEMS LTD. 244
TABLE 289 ASPECT BIOSYSTEMS LTD.: BUSINESS OVERVIEW 244
12.1.8 ADVANCED SOLUTIONS LIFE SCIENCES, LLC 246
TABLE 290 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: BUSINESS OVERVIEW 246
12.1.9 CYFUSE BIOMEDICAL K.K. 248
TABLE 291 CYFUSE BIOMEDICAL K.K.: BUSINESS OVERVIEW 248
12.1.10 ROKIT HEALTHCARE, INC. 249
TABLE 292 ROKIT HEALTHCARE, INC.: BUSINESS OVERVIEW 249
12.1.11 REGENOVO BIOTECHNOLOGY CO., LTD. (PART OF SHINING 3D TECH CO., LTD.) 250
TABLE 293 REGENOVO BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 250
12.1.12 PANDORUM TECHNOLOGIES PVT. LTD. 252
TABLE 294 PANDORUM TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW 252
12.1.13 FOLDINK LIFE SCIENCE TECHNOLOGIES 253
TABLE 295 FOLDINK LIFE SCIENCE TECHNOLOGIES: BUSINESS OVERVIEW 253
12.1.14 REVOTEK CO., LTD. 254
TABLE 296 REVOTEK CO., LTD.: BUSINESS OVERVIEW 254
12.1.15 PRECISE BIO 255
TABLE 297 PRECISE BIO: BUSINESS OVERVIEW 255
12.2 OTHER PLAYERS 256
12.2.1 BRINTER 256
12.2.2 PRELLIS BIOLOGICS 256
12.2.3 REGEMAT 3D 257
12.2.4 3DBIO THERAPEUTICS 258
12.2.5 TISSUE REGENERATION SYSTEMS INC. 258
12.2.6 POIETIS 259
12.2.7 SUNP BIOTECH, LLC 259
12.2.8 VIVAX BIO, LLC 260
12.2.9 GESIM MBH 260
12.2.10 MANCHESTER BIOGEL 261
*Details on Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 262
13.1 DISCUSSION GUIDE 262
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 267
13.3 AVAILABLE CUSTOMIZATION 269
13.4 RELATED REPORTS 269
13.5 AUTHOR DETAILS 270

★調査レポート[3Dバイオプリンティングのグローバル市場予測(~2027):3Dバイオプリンター、バイオインク] ( 3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material(Hydrogel, Living Cells), Application (Research, Clinical), End user (Biopharma, Academia) - Global Forecast to 2027 / BT4971-22) 販売に関する免責事項
[3Dバイオプリンティングのグローバル市場予測(~2027):3Dバイオプリンター、バイオインク] ( 3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material(Hydrogel, Living Cells), Application (Research, Clinical), End user (Biopharma, Academia) - Global Forecast to 2027 / BT4971-22) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆